Scinopharm Taiwan (TPE:1789) Dividend Payout Ratio: 0.00 (As of Dec. 2025)


TPE:1789 Scinopharm Taiwan Ltd TPE:1789
75 GF Score
Price NT$20.85
GF Value NT$27.15
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Scinopharm Taiwan Dividend Payout Ratio?

Scinopharm Taiwan TPE:1789 +2.71% 75 Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus rates TPE:1789 with a GF Score™ of 75/100 and a GF Value™ of NT$27.15 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 444 Drug Manufacturers companies, Scinopharm Taiwan ranks worse than 96.85% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Scinopharm Taiwan's Dividend Payout Ratio for the months ended in Dec. 2025 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Scinopharm Taiwan Ltd is 2.06, which seems too high.

The historical rank and industry rank for Scinopharm Taiwan's Dividend Payout Ratio or its related term are showing as below:

TPE:1789' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.32   Med: 0.93   Max: 2.06
Current: 2.06

During the past 13 years, the highest Dividend Payout Ratio of Scinopharm Taiwan was 2.06. The lowest was 0.32. And the median was 0.93.

TPE:1789's Dividend Payout Ratio is ranked worse than
96.85% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.375 vs TPE:1789: 2.06

As of today (2026-07-05), the Dividend Yield % of Scinopharm Taiwan is 1.39%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Scinopharm Taiwan was 4.05%. The lowest was 0.42%. And the median was 1.41%.

Scinopharm Taiwan's Dividends per Share for the months ended in Dec. 2025 was NT$0.00.

During the past 12 months, Scinopharm Taiwan's average Dividends Per Share Growth Rate was 16.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -10.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -1.50% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 4.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Scinopharm Taiwan was 131.00% per year. The lowest was -38.80% per year. And the median was -1.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Scinopharm Taiwan (TPE:1789) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Scinopharm Taiwan Dividend Payout Ratio Related Terms

Scinopharm Taiwan Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Scinopharm Taiwan's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scinopharm Taiwan Dividend Payout Ratio Chart

Scinopharm Taiwan Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.61 1.07 1.00 0.69 2.06

Scinopharm Taiwan Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 8.75 0.00 0.00

TPE:1789 vs ZTS, UTHR: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Scinopharm Taiwan's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scinopharm Taiwan Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Scinopharm Taiwan's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Scinopharm Taiwan's Dividend Payout Ratio falls into.


TPE:1789
75GF Score
Scinopharm Taiwan Ltd TPE:1789
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scinopharm Taiwan Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Scinopharm Taiwan's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0.35/ 0.17
=2.06

Scinopharm Taiwan's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0/ 0.052
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Scinopharm Taiwan (TPE:1789) has a Dividend Payout Ratio of 0.00 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Scinopharm Taiwan and its competitors. Over the past decade, Scinopharm Taiwan's Dividend Payout Ratio has ranged from 0.32 to 2.06. According to the industry distribution chart, Scinopharm Taiwan ranks #430 out of 444 companies in the Drug Manufacturers industry, placing it in the top 96.8%.
Is Scinopharm Taiwan's Dividend Payout Ratio too high?
Scinopharm Taiwan's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 2.06. Based on the distribution chart, Scinopharm Taiwan ranks #430 out of 444 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Scinopharm Taiwan has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Scinopharm Taiwan's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Scinopharm Taiwan ranks #430 out of 444 companies for Dividend Payout Ratio. This places Scinopharm Taiwan in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, Scinopharm Taiwan's own Dividend Payout Ratio has ranged from 0.32 to 2.06 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Scinopharm Taiwan and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scinopharm Taiwan's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scinopharm Taiwan stock overvalued right now?
Based on GuruFocus' analysis, Scinopharm Taiwan (TPE:1789) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$27.15, compared to a current price of NT$20.85 — trading 23.2% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Scinopharm Taiwan's overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Scinopharm Taiwan (TPE:1789), the current Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scinopharm Taiwan (TPE:1789) Overvalued in 2026?

Based on GuruFocus' analysis, Scinopharm Taiwan stock appears to be undervalued. The current stock price of NT$20.85 is trading 23.2% below its estimated GF Value™ of NT$27.15. GuruFocus considers Scinopharm Taiwan to be Modestly Undervalued.

Key valuation signals for TPE:1789:

  • Dividend Payout Ratio: 0.00
  • GF Value™: NT$27.15 vs. price of NT$20.85 (23.2% below fair value)
  • GF Score™: 75/100 with 8 warning signs

No single metric tells the full story. See the TPE:1789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scinopharm Taiwan Business Description

Address Nan-Ke 8th Road, No. 1, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144
Scinopharm Taiwan Ltd is mainly engaged in the manufacture of western medicines and other chemical materials, biological technology services, intellectual property rights, international trade, and the research, development, production, manufacture, and sales of Active Pharmaceutical Ingredients (API), albumin medicines, oligonucleotide medicines, peptide medicines, injections, and new small molecule drugs. The Company also provides related consulting and technical services and international trade for the above products. In addition, the Company sells chemical material reprocessed from material recycled from the Company's manufacturing process.
75GF Score

Get the complete analysis for TPE:1789

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.85
Price
NT$27.15
GF Value